U.S. pharma huge copyright scrapped two experimental weight loss products previous yr—a when-day by day capsule, lotiglipron, as a result of elevated liver enzymes as well as a twice-everyday capsule, danuglipron, as a result of potent side effects—but CEO Albert Bourla has stated the company is determined to “Perform and acquire” within th